The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Volume 341:217-225 July 22, 1999 Number 4
NextNext

Sex-Based Differences in Early Mortality after Myocardial Infarction
Viola Vaccarino, M.D., Ph.D., Lori Parsons, B.S., Nathan R. Every, M.D., M.P.H., Hal V. Barron, M.D., Harlan M. Krumholz, M.D., for The National Registry of Myocardial Infarction 2 Participants

 

This Article
-Abstract
- PDF

Commentary
-Editorial
 by Wexler, L. F.
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background There is conflicting information about whether short-term mortality after myocardial infarction is higher among women than among men after adjustment for age and other prognostic factors. We hypothesized that younger, but not older, women have higher mortality rates during hospitalization than their male peers.

Methods We analyzed data on 384,878 patients (155,565 women and 229,313 men) who were 30 to 89 years of age and who had been enrolled in the National Registry of Myocardial Infarction 2 between June 1994 and January 1998. Patients who had been transferred from or to other hospitals were excluded.

Results The overall mortality rate during hospitalization was 16.7 percent among the women and 11.5 percent among the men. Sex-based differences in the rates varied according to age. Among patients less than 50 years of age, the mortality rate for the women was more than twice that for the men. The difference in the rates decreased with increasing age and was no longer significant after the age of 74 (P< 0.001 for the interaction between sex and age). Logistic-regression analysis showed that the odds of death were 11.1 percent greater for women than for men with every five-year decrease in age (95 percent confidence interval, 10.1 to 12.1 percent). Differences in medical history, the clinical severity of the infarction, and early management accounted for only about one third of the difference in the risk. After adjustment for these factors, women still had a higher risk of death for every five years of decreasing age (increase in the odds of death, 7.0 percent; 95 percent confidence interval, 5.9 to 8.1 percent).

Conclusions After myocardial infarction, younger women, but not older women, have higher rates of death during hospitalization than men of the same age. The younger the age of the patients, the higher the risk of death among women relative to men. Younger women with myocardial infarction represent a high-risk group deserving of special study.


With the recognition of cardiovascular disease as the number-one cause of death among women in the United States,1 considerable interest has been focused on the study of sex-based differences in the outcome of myocardial infarction. However, after about a decade of research on this topic, studies are conflicting about whether short-term mortality after myocardial infarction is higher among women than men, after adjustment for differences in age and other prognostic factors.2,3,4,5,6,7,8,9,10,11,12,13

The traditional approach has been to compare men and women after adjustment for age and other covariables. However, younger women (those less than 65 or 70 years of age) who have a myocardial infarction may represent a distinct group in terms of risk factors and pathophysiology.14,15,16,17,18,19 We recently reported a significant interaction between sex and age with respect to short-term mortality after myocardial infarction.20 The mortality rate among women younger than 75 years of age was twice that among men in that age group, whereas we found no differences in mortality among older patients. However, our previous study was limited by a sample size that allowed stratification into only two age groups.

The purpose of the present study was to confirm the hypothesis that age has a significant effect on short-term mortality after myocardial infarction and to determine the reasons for this effect. We hypothesized that the younger the patients, the higher the risk of death during hospitalization among women relative to men.

Methods

Patients

The National Registry of Myocardial Infarction 2 is a prospective, observational study of patients admitted to the hospital with acute myocardial infarction that was initiated on June 1, 1994. Participating hospitals enroll consecutive patients with acute myocardial infarction, as described previously.21 The methods of case ascertainment and data acquisition have been validated.22 By January 31, 1998, a total of 691,995 patients from 1658 U.S. hospitals had been enrolled. In the current analysis, we excluded 143,366 patients who were transferred from a participating hospital to another acute care institution, since the outcome after transfer was not known. We also excluded 886 patients with missing information on age, 16,925 patients who were 90 years of age or older, and 1189 patients who were less than 30 years of age, since myocardial infarction is rare in this age group, particularly among women. In our main analysis we also excluded 144,751 patients who had been transferred from other acute care hospitals, since admission data were often missing and, when they were not, they were thought to be less accurate. Therefore, 384,878 patients (155,565 women and 229,313 men) were included in this analysis. Since transferred patients accounted for 22 percent of all patients in the registry, and since more men (23.8 percent) than women (19.0 percent) had been transferred, we repeated the analyses with the sample that included patients who had been transferred to participating hospitals.

Clinical Variables

Information on clinical variables (Table 1) was abstracted from the medical records at each hospital.21 The degree of ventricular dysfunction was assessed with use of the Killip classification.23

View this table:
[in this window]
[in a new window]
 
Table 1. Base-Line Characteristics of the Patients, Early Treatments, and Characteristics of the Hospitals in the Entire Group and According to Age.

 
Statistical Analysis

First, we compared the mortality rate during hospitalization among women and men according to five-year age groups. We used the Breslow–Day test to assess whether there was an interaction between age and sex.24 Next, we compared the base-line characteristics of the women and men, treatment factors, events that occurred during hospitalization, and characteristics of the hospitals with the use of four age groups (30 to 59 years, 60 to 69 years, 70 to 79 years, and 80 to 89 years). We then used a series of logistic-regression models to assess the effect of groups of variables on the associations of interest (sex and its interaction with age). We calculated odds ratios with their 95 percent confidence intervals from these models.

The first model included sex as an explanatory variable. In subsequent models, we added sequentially age, the interaction between sex and age, other demographic factors (race and insurance status), coexisting conditions (myocardial infarction, angina, congestive heart failure, stroke, coronary-artery bypass grafting, percutaneous transluminal coronary angioplasty, hypertension, diabetes, hypercholesterolemia, and current smoking), clinical indicators of the severity of the infarction, management in the first 24 hours after infarction, time from the onset of symptoms to presentation at the hospital, and characteristics of the hospitals. Each model also included three dummy variables for the year of discharge (1994, 1995, and 1996, with 1997–1998 used as the reference category). Given the large number of patients and the fact that all the candidate variables were deemed relevant, the size of the model was not reduced. In the case of two variables for which data were missing for at least 5 percent of patients — time to presentation (data missing for 33 percent) and left ventricular ejection fraction (data missing for 42 percent) — a dummy variable for the missing values was added to the models.

Age and its interaction with sex were modeled as continuous variables, since no significant departure from linear trend was found, consistent with the results of previous studies25 and indicating an exponential increase in the odds of death with age. The odds of death for women as compared with men were calculated according to five-year decrements in age (from old to young). The adequacy of fit and the discriminatory power of the models were assessed according to standard methods.26,27 All tests of statistical significance were two-tailed.

Results

Bivariate Analyses and Comparisons of Men and Women According to Age

As expected, the female patients were older than the male patients: the mean (±SD) age of the women was 72.4±12.0 years, whereas that of the men was 65.6±13.1 years (P<0.001). The mortality rate during hospitalization was higher among women than among men (16.7 percent vs. 11.5 percent; odds ratio for death among women as compared with men, 1.54; 95 percent confidence interval, 1.51 to 1.57). However, when the mortality rates were examined according to age group, sex-based differences varied according to age (Figure 1). In the group of patients who were less than 50 years of age, the mortality rate during hospitalization was more than twice as high among the women. The difference in the rates decreased with increasing age and was no longer significant after the age of 74 (P<0.001 for the overall interaction between sex and age).


View larger version (11K):
[in this window]
[in a new window]
 
Figure 1. Rates of Death during Hospitalization for Myocardial Infarction among Women and Men, According to Age.

The interaction between sex and age was significant (P<0.001).

 
Younger women were more likely than younger men to have diabetes, a history of congestive heart failure, and a history of stroke, but no sex-based differences were apparent at older ages (Table 1). At all ages men were more likely than women to have a history of myocardial infarction, coronary-artery bypass grafting, and coronary angioplasty and to be smokers. At younger ages women were more likely than men to be given a diagnosis other than myocardial infarction or unstable angina at admission, whereas the diagnoses at admission were similar among older men and women.

There were also age-related differences between men and women in the clinical characteristics at admission (Table 1). Younger women, but not older women, were more likely than men to have more severe clinical abnormalities (i.e., higher Killip class, lower systolic blood pressure, and higher pulse rate), but they were less likely than their male peers to have chest pain and ST elevation on the initial electrocardiogram. Sex-based differences in treatment in the first 24 hours were small, but there was a consistent pattern of a lower likelihood of treatment among the women, in particular at younger ages. The characteristics of the hospital and the years of discharge were similar among the women and men.

Overall, the locations of the infarcts, creatine kinase levels, and left ventricular ejection fractions (among patients in whom ejection fraction was assessed) were similar among the women and men (Table 2). Nonetheless, younger women were more likely than younger men to have complications such as hypotension, heart failure, cardiogenic shock, and major bleeding and were less likely to undergo cardiovascular procedures such as coronary angiography and revascularization (Table 2).

View this table:
[in this window]
[in a new window]
 
Table 2. Characteristics during Hospitalization in the Entire Group and According to Age.

 
Multivariable Analyses

Adjustment of the logistic-regression model for age appeared to account for most of the effect of sex on the mortality rate: the odds ratio for death among women decreased from 1.54 to 1.18 (95 percent confidence interval, 1.16 to 1.20). However, when the interaction between sex and age was included in the model, it was found to be significant (P<0.001): for every five-year decrease in age, the odds of death during hospitalization for women relative to men increased 11.1 percent (95 percent confidence interval, 10.1 to 12.1 percent). Sex-based differences in medical history, clinical severity of the infarction, and early management accounted for about one third of the difference (Table 3, Figure 2A, and Figure 2B). After adjustment for all the variables listed in Table 1, women still had a higher risk of death for every five-year decrement in age (increase in the odds of death, 7.0 percent; 95 percent confidence interval, 5.9 to 8.1 percent). The addition of the hospitals' characteristics to the model did not change the estimate for sex or for the interaction between sex and age. In every model the interaction between sex and age remained significant.

View this table:
[in this window]
[in a new window]
 
Table 3. Variation of the Effect of Sex on the Risk of Death during Hospitalization for Every Five-Year Decrement in Age and the Effect of Adding Covariables.

 


View larger version (6K):
[in this window]
[in a new window]
 
Figure 2. Odds Ratios for Death during Hospitalization for Myocardial Infarction in Women as Compared with Men, According to Age.

The unadjusted odds ratios (Panel A) were derived from the model that included sex, age, the interaction between sex and age, and the year of discharge. The adjusted odds ratios (Panel B) were derived from the model that also included race, insurance status, medical history, severity of clinical abnormalities at admission, type of management in the first 24 hours after admission, and time to presentation.

 
Previous studies have reported that diabetes may be a stronger prognostic factor after myocardial infarction in women than in men.28,29 Therefore, as a post hoc analysis, we checked whether there was a significant interaction between sex and diabetes with respect to the mortality rate in the age group in which most sex-based differences in the rate were found (patients less than 70 years of age). No significant interaction between sex and diabetes was found (P=0.30).

The fit of the model appeared to be satisfactory. When the analyses were repeated in the group that also included the patients who had transferred to participating hospitals, the results were similar (data not shown).

Discussion

Consistent with previous findings,5,7,30,31,32,33,34,35,36,37,38,39,40,41,42,43 we found that women as a group had a higher unadjusted risk of early death after myocardial infarction than men, and older age was an important potential explanation for this higher risk. However, examination of the results according to age revealed a different explanation. The risk among women was higher only before the age of about 75, was not accounted for by other characteristics in the analysis, and increased progressively with decreasing age. This study confirms our preliminary report,20 which was limited by the sample size. In both studies an elevated risk of early death among women relative to men gradually decreased with age and was seen only up to the age of approximately 75.

In line with epidemiologic,44 pathological,16 and physiologic17 data, our results provide clinical evidence that women who have a myocardial infarction are a heterogeneous group; our findings thus further clarify whether female sex is a risk factor for short-term mortality after myocardial infarction. Studies of elderly patients with myocardial infarction have consistently found either no significant differences in the mortality rate between men and women45,46 or a lower rate among women.47,48 In contrast, studies that have excluded elderly patients33,49,50 have tended to show higher mortality rates among women, even after adjustment for base-line differences. Most studies, however, included patients over a wide age range. The failure to account for a variation in the effect of sex according to age may have led to inaccurate risk estimates.

Studies based on patients who were enrolled in clinical trials5,10,11,49,50 or who met eligibility criteria for thrombolysis8 have also tended to show higher mortality rates during hospitalization or at one month among women than among men. For example, the Third International Study of Infarct Survival analyzed mortality data according to age and sex and found no interaction between sex and age.5 All the patients were seen within 24 hours after the onset of symptoms and had "clear indications" for thrombolytic therapy, as well as no contraindications. These selection criteria may explain in part the differences in results between those studies and our study. In our study younger women waited longer than men before going to the hospital, were less likely to be given a diagnosis of myocardial infarction at admission, and were less likely to receive thrombolytic therapy. Therefore, these women would most likely have been excluded from trials of thrombolytic therapy. Selection factors other than eligibility for treatment may also have a role, since a large proportion of eligible patients are usually not enrolled in randomized trials and certain types of patients are favored for inclusion.51

Epidemiologic data have indicated that women are relatively spared from coronary heart disease up to the age of 75.44 Although the reasons for this protection are not entirely clear, estrogen is thought to play a part.52 Women in whom coronary atherosclerosis develops before the age of 75 may be predisposed to have particularly aggressive disease or possibly early onset or may have more risk factors for coronary heart disease, which might override the protective effect of estrogen. For example, diabetes has been found to negate the protective effect of female sex against coronary heart disease and death from cardiovascular disease53,54 and to be a stronger prognostic factor after myocardial infarction in women than in men.28,29 In our study, younger women, but not older women, were more likely to have diabetes than their male peers. The higher risk of diabetes was paralleled by a more frequent history of heart failure and stroke in younger women than in younger men. However, adjustment for diabetes and other coexisting conditions accounted for only about 10 percent of the difference in the risk, and there was no significant interaction between sex and diabetes.

Another possible explanation for the higher risk of death among younger women is the lower rate of use of established treatments for myocardial infarction, such as aspirin, beta-blockers, and thrombolytic therapy, in women.3 Sex-based differences in these treatments have been reported.55,56,57 In one study, female sex remained an independent predictor of the lack of use of reperfusion therapy among eligible patients.57 However, after adjustment, treatment differences accounted for only about 10 percent of the effect of the interaction between sex and age in our study, possibly because the severity of the clinical abnormalities was already in the model. The latter variable had the strongest impact, accounting for 19 percent of the effect of the interaction between sex and age.

The pathophysiology of coronary heart disease in premenopausal or middle-aged women may differ from the more common disease of older women and of men. Plaque erosions are the predominant abnormality in premenopausal women who die suddenly, whereas rupture of plaques is more common in older women and in men.16 In addition, younger women who have a myocardial infarction,14 who die suddenly of coronary causes,16 or who survive a cardiac arrest15 have less narrowing of the coronary arteries than older women or men. These findings suggest that different clotting mechanisms may trigger myocardial infarction in younger women, perhaps involving a hypercoagulable state or coronary spasm. Young women who survive myocardial infarction have more reactive platelets than young male survivors,17 and transmural myocardial infarction with normal findings on coronary angiography, which is distinctly more common in young women, has been associated with vasospastic syndromes such as migraine and Raynaud's phenomenon, as well as hypercoagulable states such as pregnancy and use of oral contraceptives.18 These and other mechanisms may be genetic in nature or have a genetic predisposition. A family history of death from coronary heart disease is associated with an increased risk of this event in both men and women, but this susceptibility is stronger in younger women than in older women or in men.58

It is also possible that the higher rate of death during hospitalization among younger women is due to sex-based differences in the mortality rate before hospitalization. Studies of two registries participating in the World Health Organization's Monitoring Trends and Determinants in Cardiovascular Disease Project,42,43 which assesses coronary events in people less than 64 years of age, have shown that a higher rate of death from myocardial infarction during hospitalization among women is balanced by a higher rate of death before hospitalization among men. However, a study of the project's entire registry, involving 29 populations in 18 countries, found considerable variation in the rates of death before hospitalization.13 Therefore, this issue needs further clarification.

The peculiar characteristics of coronary heart disease in young and middle-aged women may have diagnostic implications that affect management decisions and, therefore, prognosis. The less extensive narrowing of coronary arteries in these women may cause underdiagnosis of coronary heart disease with the use of traditional diagnostic tests such as coronary angiography. Studies have suggested that women with symptoms of coronary heart disease are referred for cardiovascular procedures less often59,60,61 or later62 than men. Some of these differences may reflect differences in the characteristics of early manifestations of coronary heart disease in women, as suggested by our findings of age-based differences in the presentation of myocardial infarction. If the early symptoms, signs, and pathophysiology of coronary heart disease in women differ from those in men, the condition may be more difficult to recognize in women at an early stage.

A strength of our study, in addition to the use of a large number of patients from several states, is its observational design. Consent procedures or eligibility for treatment was not required for enrollment, therefore minimizing bias and increasing the generalizability of results. Although the data we collected were not independently validated, our methods of case ascertainment and acquisition of other data have been found to be valid.22 In addition, the simplicity of the protocol enabled us to assemble one of the largest and most contemporary data bases of myocardial infarction in the United States. Although the use of death during hospitalization as the end point (with an average length of stay of about 7 days) may decrease the comparability of our results with those of other investigations that have used 28-to-35-day mortality as the end point,4,5,7,43 most deaths after hospital admission for myocardial infarction occur early, most commonly in the first 24 hours.13

In conclusion, we found that the higher short-term mortality of women, as compared with men, after myocardial infarction was confined to women who were less than 75 years of age — the age group in which myocardial infarction can be considered premature in women. In addition, the younger the age of the women, the higher the risk of death relative to men. This higher risk was only partially accounted for by differences in coexisting conditions, clinical characteristics, and early management. Our results indicate that younger women with myocardial infarction are a high-risk group deserving of special study and that patients' age must be considered in assessments of sex-based differences in short-term mortality after myocardial infarction.

Dr. Krumholz is a Paul Beeson Faculty Scholar.

We are indebted to Dr. Judy Malmgren for her expertise in the management of study data.

* A complete list of the participating hospitals is available from ClinTrials Research, 1100 Weston Pkwy., Cary, NC 27513.


Source Information

From the Departments of Epidemiology and Public Health (V.V., H.M.K.) and Medicine (Cardiology) (H.M.K.), Yale University School of Medicine, New Haven, Conn.; the Health Services Research and Development Field Program, Veterans Affairs Puget Sound Healthcare System, and the Cardiovascular Outcomes Research Center, Division of Cardiology, University of Washington School of Medicine, Seattle (L.P., N.R.E.); the Division of Cardiology, University of California–San Francisco, and the Division of Medical Affairs, Genentech, San Francisco (H.V.B.); and the Center for Outcomes Research and Evaluation, Yale–New Haven Hospital, New Haven, Conn. (H.M.K.).

Address reprint requests to Dr. Vaccarino at the Department of Epidemiology and Public Health, Yale University School of Medicine, 60 College St., P.O. Box 208034, New Haven, CT 06520-8034, or at viola.vaccarino{at}yale.edu.

References

  1. Wenger NK, Speroff L, Packard B. Cardiovascular health and disease in women. N Engl J Med 1993;329:247-256. [Free Full Text]
  2. Vaccarino V, Krumholz HM, Berkman LF, Horwitz RI. Sex differences in mortality after myocardial infarction: is there evidence for an increased risk for women? Circulation 1995;91:1861-1871. [Free Full Text]
  3. Nohria A, Vaccarino V, Krumholz HM. Gender differences in mortality after myocardial infarction: why women fare worse than men. Cardiol Clin 1998;16:45-57. [CrossRef][Medline]
  4. Marrugat J, Sala J, Masia R, et al. Mortality differences between men and women following first myocardial infarction. JAMA 1998;280:1405-1409. [Free Full Text]
  5. Malacrida R, Genoni M, Maggioni AP, et al. A comparison of the early outcome of acute myocardial infarction in women and in men. N Engl J Med 1998;338:8-14. [Free Full Text]
  6. Coronado BE, Griffith JL, Beshansky JR, Selker HP. Hospital mortality in women and men with acute cardiac ischemia: a prospective multicenter study. J Am Coll Cardiol 1997;29:1490-1496. [Abstract]
  7. Herman B, Greiser E, Pohlabeln H. A sex difference in short-term survival after initial acute myocardial infarction: the MONICA-Bremen Acute Myocardial Infarction Register, 1985-1990. Eur Heart J 1997;18:963-970. [Free Full Text]
  8. Kudenchuck PJ, Maynard C, Martin JS, Wirkus M, Weaver WD. Comparison of presentation, treatment, and outcome of acute myocardial infarction in men versus women. Am J Cardiol 1996;78:9-14. [Medline]
  9. Maynard C, Every NR, Martin JS, Kudenchuk PJ, Weaver WD. Association of gender and survival in patients with acute myocardial infarction. Arch Intern Med 1997;157:1379-1384. [Free Full Text]
  10. Weaver WD, White HD, Wilcox RG, et al. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. JAMA 1996;275:777-782. [Free Full Text]
  11. Woodfield SL, Lundergan CF, Reiner JS, et al. Gender and acute myocardial infarction: is there a different response to thrombolysis? J Am Coll Cardiol 1997;29:35-42. [Abstract]
  12. Kober L, Torp-Pedersen C, Ottensen M, Rasmussen S, Lessing M, Skagen K. Influence of gender on short- and long-term mortality after acute myocardial infarction. Am J Cardiol 1996;77:1052-1056. [CrossRef][Medline]
  13. Chambless L, Keil U, Dobson A, et al. Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA project 1985-1990. Circulation 1997;96:3849-3859. [Free Full Text]
  14. Johansson S, Bergstrand R, Ulvenstam G, et al. Sex differences in preinfarction characteristics and longterm survival among patients with myocardial infarction. Am J Epidemiol 1984;119:610-623. [Free Full Text]
  15. Albert CM, McGovern BA, Newell JB, Ruskin JM. Sex differences in cardiac arrest survivors. Circulation 1996;93:1170-1176. [Free Full Text]
  16. Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 1998;97:2110-2116. [Free Full Text]
  17. Berglund U, Wallentin L, von Schenck H. Platelet function and plasma fibrinogen and their relations to gender, smoking habits, obesity and beta-blocker treatment in young survivors of myocardial infarction. Thromb Haemost 1988;60:21-24. [Medline]
  18. Ciraulo DA, Bresnahan GF, Frankel PS, Isely PE, Zimmerman WR, Chesne RB. Transmural myocardial infarction with normal coronary angiograms and with single vessel coronary obstruction: clinical-angiographic features and five-year follow-up. Chest 1983;2:196-202. 
  19. Heupler FA Jr. Syndrome of symptomatic coronary arterial spasm with nearly normal coronary arteriograms. Am J Cardiol 1980;45:873-881. [CrossRef][Medline]
  20. Vaccarino V, Horwitz RI, Meehan TP, Petrillo MK, Radford MJ, Krumholz HM. Sex differences in mortality after myocardial infarction: evidence for a sex-age interaction. Arch Intern Med 1998;158:2054-2062. [Free Full Text]
  21. Barron HV, Michaels AD, Maynard C, Every NR. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. J Am Coll Cardiol 1998;32:360-367. [Free Full Text]
  22. Every NR, Fredrick PD, Robinson M, Sugarman J, Bowlby L, Barron HV. A comparison of the National Registry of Myocardial Infarction 2 with the Cooperative Cardiovascular Project. J Am Coll Cardiol 1999;33:1886-1894. [Free Full Text]
  23. Killip T III, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two-year experience with 250 patients. Am J Cardiol 1967;20:467-474. 
  24. Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980. (IARC scientific publications no. 32.)
  25. Maggioni AP, Maseri A, Fresco C, et al. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. N Engl J Med 1993;329:1442-1448. [Free Full Text]
  26. Cox DR, Snell EJ. Analysis of binary data. 2nd ed. London: Chapman & Hall, 1989.
  27. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36. [Free Full Text]
  28. Donahue RP, Goldberg RJ, Chen Z, Gore JM, Alpert JS. The influence of sex and diabetes mellitus on survival following acute myocardial infarction: a community-wide perspective. J Clin Epidemiol 1992;46:245-252. 
  29. Abbott RD, Donahue RP, Kannel WB, Wilson PWF. The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham Study. JAMA 1988;260:3456-3460. [Erratum, JAMA 1989;261:1884.] [Free Full Text]
  30. Dittrich H, Gilpin E, Nicod P, Cali G, Henning H, Ross J Jr. Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol 1988;62:1-7. [Medline]
  31. Goldberg RJ, Gorak EJ, Yarzebski J, et al. A community-wide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation 1993;87:1947-1953. [Free Full Text]
  32. Hammar N, Larsen FF, Sandberg E, Alfredsson L, Theorell T. Time trends in survival from myocardial infarction in Stockholm County 1976-1984. Int J Epidemiol 1992;21:1090-1096. [Free Full Text]
  33. Fiebach NH, Viscoli CM, Horwitz RI. Differences between women and men in survival after myocardial infarction: biology or methodology? JAMA 1990;263:1092-1096. [Free Full Text]
  34. Karlson BW, Herlitz J, Hartford M. Prognosis in myocardial infarction in relation to gender. Am Heart J 1994;128:477-483. [CrossRef][Medline]
  35. Krumholz HM, Douglas PS, Lauer MS, Pasternak RC. Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for a gender bias? Ann Intern Med 1992;116:785-790.
  36. Marrugat J, Anto JM, Sala J, Masia R. Influence of gender in acute and long-term cardiac mortality after a first myocardial infarction. J Clin Epidemiol 1994;47:111-118. [CrossRef][Medline]
  37. Maynard C, Litwin PE, Martin JS, Weaver WD. Gender differences in the treatment and outcome of acute myocardial infarction: results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med 1992;152:972-976. [Free Full Text]
  38. Peter T, Harper R, Luxton M, Penington C, Sloman JG. Acute myocardial infarction in women: the influence of age on complications and mortality. Med J Aust 1978;1:189-191. [Medline]
  39. Robinson K, Conroy RM, Mulcahy R, Hickey N. Risk factors and in-hospital course of first episode of myocardial infarction or acute coronary insufficiency in women. J Am Coll Cardiol 1988;11:932-936. [Abstract]
  40. Weinblatt E, Shapiro S, Frank CW. Prognosis of women with newly diagnosed coronary heart disease: a comparison with course of disease among men. Am J Public Health 1973;63:577-593. [Free Full Text]
  41. White HD, Barbash GI, Modan M, et al. After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. Circulation 1993;88:2097-2103. [Free Full Text]
  42. Sonke GS, Beaglehole R, Stewart AW, Jackson R, Stewart FM. Sex differences in case fatality before and after admission to hospital after acute cardiac events: analysis of community based coronary heart disease register. BMJ 1996;313:853-855. [Free Full Text]
  43. Tunstall-Pedoe H, Morrison C, Woodward M, Fitzpatrick B, Watt G. Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991: presentation, diagnosis, treatment, and 28-day case fatality of 3991 events in men and 1551 events in women. Circulation 1996;93:1981-1982. [Free Full Text]
  44. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986;111:383-390. [CrossRef][Medline]
  45. Bueno H, Vidan MT, Almazan A, Lopez-Sendon JL, Delcan JL. Influence of sex on the short-term outcome of elderly patients with a first acute myocardial infarction. Circulation 1995;92:1133-1140. [Free Full Text]
  46. Maynard C, Litwin PE, Martin JS, Weaver WD. Treatment and outcome of acute myocardial infarction in women 75 years of age and older: findings from the Myocardial Infarction Triage and Intervention Registry. Cardiol Elderly 1993;1:121-5.
  47. Udvarhelyi IS, Gatsonis C, Epstein AM, Pashos CL, Newhouse JP, McNeil BJ. Acute myocardial infarction in the Medicare population: process of care and clinical outcomes. JAMA 1992;268:2530-2536. [Free Full Text]
  48. Vaccarino V, Krumholz HM, Mendes de Leon CF, Holford TE, Horwitz RI, Berkman LF. Sex differences in survival after myocardial infarction in older adults: a community-based approach. J Am Geriatr Soc 1996;44:1174-1182. [Medline]
  49. Tofler GH, Stone PH, Muller JE, et al. Effect of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol 1987;9:473-482. [Abstract]
  50. Becker RC, Terrin M, Ross R, et al. Comparison of clinical outcomes for women and men after acute myocardial infarction. Ann Intern Med 1994;120:638-645. [Free Full Text]
  51. Friedman LM, Furberg CD, DeMets DL. Fundamentals of clinical trials. 3rd ed. New York: Springer-Verlag, 1998.
  52. Herrington DM. Sex hormones and normal cardiovascular physiology in women. In: Julian DG, Wenger NK, eds. Women and heart disease. St. Louis: Mosby–Year Book, 1997:243-64.
  53. Barrett-Connor EL, Cohn BA, Wingard DL, Eldestein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991;265:627-631. [Erratum, JAMA 1991;265:3249.] [Free Full Text]
  54. Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 1998;158:617-621. [Free Full Text]
  55. Chandra NC, Ziegelstein RC, Rogers WJ, et al. Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction -- I. Arch Intern Med 1998;158:981-988. [Free Full Text]
  56. Gurwitz JH, Gore JM, Goldberg RJ, Rubison M, Chandra N, Rogers WJ. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction: National Registry of Myocardial Infarction. Ann Intern Med 1996;124:283-291. [Free Full Text]
  57. Barron HV, Bowlby LJ, Breen T, et al. Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Circulation 1998;97:1150-1156. [Free Full Text]
  58. Marenberg ME, Risch N, Berkman LF, Floderus B, De Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994;330:1041-1046. [Free Full Text]
  59. Tobin J, Wassertheil-Smoller S, Wexler JP, et al. Sex bias in considering coronary bypass surgery. Ann Intern Med 1987;107:19-25.
  60. Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med 1991;325:221-225. [Abstract]
  61. Steingart RM, Packer M, Hamm P, et al. Sex differences in the management of coronary artery disease. N Engl J Med 1991;325:226-230. [Abstract]
  62. Khan SS, Nessim S, Gray R, Czer LS, Chaux A, Matloff J. Increased mortality of women in coronary artery bypass surgery: evidence for referral bias. Ann Intern Med 1990;112:561-567.

 

This Article
-Abstract
- PDF

Commentary
-Editorial
 by Wexler, L. F.
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation

Related Letters:

Coronary Artery Disease in Men and Women
Rosén M., Spetz C.-L., Hammar N., Greenland P., Goldbourt U., Cao L., Song W., Ornstein D. L., Zacharski L. R., Vaccarino V., Hochman J. S., Thompson T. D.
Extract | Full Text  
N Engl J Med 1999; 341:1931-1935, Dec 16, 1999. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.